Similar survival seen for PET-CT-guided surveillance and planned neck dissection, but fewer operations.
Positron emission tomography (PET) imaging may offer a superior method of imaging for metastatic prostate cancer.
PET deemed safe for use after two cycles of BEACOPPesc chemotherapy for advanced stage Hodgkin lymphoma, according to a recent study.
From 1998 to 2007, more PET scans for married, non-black, <80-year-old patients with lung cancer were performed.
Advances in imaging for breast cancer screening, diagnosis, and response assessment are more promising now than ever before.
F-18-FDG PET more sensitive, equally specific to CT for assessing regional lymph node involvement.
Doctors may be able to use pretreatment PET imaging to better fight aggressive cancers, according to a study presented at the 2010 Multidisciplinary Head and Neck Cancer Symposium in Chandler, Arizona.
Sign Up for Free e-newsletters
- Chemotherapy-Related Fatigue Linked to Levothyroxine Use in Breast Cancer
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Obesity, Male Gender May Improve Survival Outcomes with Targeted and Immunotherapy in Melanoma
- Factors Affecting Employment Participation in Early-stage Breast Cancer
- Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment
- Zinc Sulfate Improves Chemotherapy-Induced Mucositis Outcomes in Leukemia
- 5-Year Overall Survival in Endometrial Cancer Not Improved With Chemoradiotherapy
- Travel Distance to Prostate Cancer Treatment Influences Treatment Choice
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Cisplatin-Induced Adverse Events in Osteosarcoma Not Improved With Pantoprazole
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|